Managing EPCIS Exceptions: Reducing Quarantine Delays in Pharmacy Operations

Exception management under DSCSA is becoming a defining operational challenge for pharmacies. As pharmacies continue to adapt to the Drug Supply Chain Security Act (DSCSA) requirements, managing EPCIS-related exceptions has emerged as one of the most persistent operational challenges.

DSCSA compliance depends on the ability of trading partners to exchange, validate, and reconcile serialized product data at scale. For pharmacies, this has shifted exception management from an occasional compliance task to a continuous operational function that touches receiving, inventory management, dispensing, compliance, and IT teams.

Among the most disruptive challenges are EPCIS data errors that force pharmacies to quarantine product, request supplier corrections, and pause downstream workflows, often due to system-enforced holds or standard operating procedures required to maintain compliance. These delays reduce inventory availability and can negatively impact patient access to prescribed drugs, inventory accuracy, and overall regulatory confidence.

This overview examines why EPCIS-related exceptions occur, how they affect day-to-day pharmacy operations, and what changes are possible when integration challenges are addressed.

As exception volumes increase, many pharmacies are discovering that manual reconciliation processes and fragmented systems are not sustainable at scale. Managing EPCIS exceptions effectively often requires more than procedural updates; it requires structured, interoperable systems designed to validate, categorize, and resolve discrepancies within a controlled workflow.

Understanding the Core Issue: EPCIS Errors and Quarantined Inventory

EPCIS data integrity is foundational to efficient pharmacy operations and DSCSA compliance. Under DSCSA, trading partners must exchange accurate, complete, and timely EPCIS data to support product tracing, verification, and accountability across the supply chain.

When EPCIS data is missing, misaligned, or structurally incorrect, pharmacies may be unable to reconcile physical inventory with electronic transaction records. In many cases, pharmacy systems are designed to automatically flag or block product movement until discrepancies are resolved, leaving limited flexibility at the operational level.

Common EPCIS-Related Issues

• Missing or incomplete transaction data required for traceability

• Mismatched Global Trade Item Numbers (GTINs), serial numbers, or lot information between physical product and EPCIS files

• Timing discrepancies between physical receipt and EPCIS file transmission, particularly in high-volume environments

• Data formatting, mapping, or integration errors between wholesalers, manufacturers, and pharmacy systems

When these issues occur, pharmacies often have no operational or system-level alternative but to quarantine affected products until discrepancies are resolved. While necessary for compliance, this response introduces operational friction as transaction volumes increase.

How Exceptions Impact Pharmacy Workflows

EPCIS exceptions introduce several downstream consequences for pharmacy operations, extending well beyond initial receiving activities.

Inventory Holds and Space Constraints

Quarantined product occupies both physical and system inventory, reducing available stock for dispensing or transfers and complicating replenishment planning and demand forecasting.

Manual Resolution Effort

Staff must identify the root cause of the exception, determine whether it is data-related or shipment-related, coordinate internally across compliance and operations teams, and document findings for audit readiness.

Supplier Outreach and Follow-Up

Pharmacies frequently need to contact wholesalers or manufacturers to request corrected EPCIS files, track response timelines, and validate resubmitted data before product can be released.

Operational Delays

Dispensing, internal transfers, reconciliations, and downstream workflows may be paused until issues are resolved, impacting service levels, internal SLAs, and patient satisfaction.

Over time, this process can become repetitive and time-consuming, particularly when exceptions are frequent or suppliers have inconsistent response times.

For pharmacy leadership, frequent quarantines and delayed resolutions translate into measurable operational strain: reduced inventory availability, higher labor allocation toward reconciliation tasks, and increased risk exposure during audits. As exception volumes grow, these hidden costs compound quickly.

What Integration Issues Mean for DSCSA Compliance

DSCSA is not solely a documentation requirement; it is fundamentally an interoperability mandate. The law’s long-term intent is to enable secure, electronic, and interoperable tracing of prescription drugs across the supply chain.

Persistent EPCIS exchange issues undermine this objective by preventing timely product verification and end-to-end traceability. When exceptions remain unresolved, pharmacies may face challenges producing complete transaction histories during audits, investigations, or recalls.

Compliance Risks Include

• Delayed or incomplete traceability during regulatory audits or investigations

• Increased likelihood of procedural deviations and undocumented workarounds

• Reduced confidence in data integrity across trading partners and internal systems

While quarantining product is the correct immediate response to EPCIS discrepancies, long-term reliance on manual exception handling is not sustainable as enforcement expectations increase, data volumes grow, and pharmacies manage higher levels of serialized inventory.

As enforcement expectations continue to evolve, reliance on email-based correction requests, spreadsheets, or disconnected tracking tools becomes increasingly difficult to defend during audits. Sustainable compliance requires structured visibility across the entire exception lifecycle.

The Ideal Workflow Once Integration Issues Are Resolved

This workflow reflects the practical intent of DSCSA interoperability requirements. When EPCIS integrations function as designed, exception management shifts from a reactive, manual process to a controlled, system-driven operational workflow.

Achieving this state typically requires centralized validation engines, standardized exception categorization, and real-time synchronization between trading partner data and pharmacy inventory systems.

In practice, when integrations are functioning as expected:

• EPCIS data is received, automatically validated, and reconciled against physical inventory in near real time

• Exceptions are clearly categorized and prioritized, enabling teams to distinguish true data integrity issues from timing or transmission delays

• Supplier correction requests are standardized, traceable, and auditable within centralized workflows

• Once corrected data is received, quarantined product can be released promptly without redundant manual checks or rework

This approach reduces the operational burden associated with exception handling and improves predictability across pharmacy workflows. Pharmacies benefit from faster inventory availability, fewer workflow interruptions, improved staff efficiency, and stronger DSCSA readiness as transaction volumes continue to increase.

Why Exception Management Deserves Strategic Attention

Exception management is often treated as a secondary outcome of compliance requirements. In practice, it is a critical operational function that directly affects efficiency, compliance posture, inventory utilization, staff productivity, and patient service.

As DSCSA requirements mature and enforcement scrutiny increases, pharmacies are managing larger volumes of serialized data across more complex supply chains.

Pharmacies that invest in integrated approaches to exception management are better equipped to manage higher transaction volumes, reduce operational risk, support audit readiness, and maintain consistent service levels as regulatory expectations increase.

Treating exception management as a strategic capability rather than a reactive compliance task enables pharmacies to reduce quarantine durations, improve audit confidence, and protect patient access to critical medications. Organizations that invest in interoperable systems and structured workflows position themselves to scale with greater stability as serialized data volumes increase.

Looking Ahead

As DSCSA enforcement expectations continue to evolve, pharmacies evaluating their exception management strategies should consider how structured platforms, automated validation, and interoperable workflows support more efficient operations.

Dedicated systems can help centralize EPCIS data validation, exception categorization, supplier communication, and audit documentation, reducing reliance on manual tracking methods and improving visibility across the exception lifecycle.

Solutions such as LSPedia’s Pharmacy Pro are designed to support pharmacies navigating DSCSA-related requirements, including EPCIS integration and exception management.

Pharmacy Pro centralizes EPCIS validation, streamlines exception categorization, and supports structured supplier communication within a single interoperable workflow. By reducing manual tracking and improving visibility across the exception lifecycle, pharmacies can shorten quarantine durations and strengthen DSCSA readiness.

While each organization’s needs differ, having interoperable systems and structured workflows in place can significantly reduce the operational burden associated with EPCIS errors.

For organizations working to reduce EPCIS-related quarantine delays and improve exception visibility, evaluating how current systems support validation, reconciliation, and supplier coordination is a practical next step. LSPedia’s Pharmacy Pro is built to help pharmacies move from reactive exception handling to a more structured, scalable, and audit-ready approach, and our team would be happy to discuss how LSPedia can support your EPCIS integration and exception management strategy.

‍